These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32592364)

  • 21. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
    van Monsjou HS; van Velthuysen ML; van den Brekel MW; Jordanova ES; Melief CJ; Balm AJ
    Int J Cancer; 2012 Apr; 130(8):1806-12. PubMed ID: 21607949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer.
    Zhao N; Ang MK; Yin XY; Patel MR; Fritchie K; Thorne L; Muldrew KL; Hayward MC; Sun W; Wilkerson MD; Chera BS; Hackman T; Zanation AM; Grilley-Olson JE; Couch ME; Shockley WW; Weissler MC; Shores CG; Funkhouser WK; Olshan AF; Hayes DN
    Br J Cancer; 2012 Jul; 107(3):482-90. PubMed ID: 22735904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma.
    Weiss BG; Anczykowski MZ; Küffer S; Spiegel JL; Bertlich M; Canis M; Ihler F; Kitz J; Jakob M
    Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1983-2000. PubMed ID: 32814982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore.
    Tan LS; Fredrik P; Ker L; Yu FG; Wang Y; Goh BC; Loh KS; Lim CM
    Oncotarget; 2016 Dec; 7(52):86730-86739. PubMed ID: 27893418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation.
    Baschnagel AM; Williams L; Hanna A; Chen PY; Krauss DJ; Pruetz BL; Akervall J; Wilson GD
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):701-7. PubMed ID: 24521684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence and clinicopathological correlation of human papillomavirus in head and neck squamous cell carcinoma in India: A systematic review article.
    Nandi S; Mandal A; Chhebbi M
    Cancer Treat Res Commun; 2021; 26():100301. PubMed ID: 33401132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.
    Kong CS; Narasimhan B; Cao H; Kwok S; Erickson JP; Koong A; Pourmand N; Le QT
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):553-61. PubMed ID: 19427557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of p16 immunostaining in cell-blocks with corresponding tissue specimens for squamous cell carcinomas of the oropharynx.
    Song SJ; Jalaly JB
    Cytopathology; 2021 Jan; 32(1):100-107. PubMed ID: 32886831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature.
    Masand RP; El-Mofty SK; Ma XJ; Luo Y; Flanagan JJ; Lewis JS
    Head Neck Pathol; 2011 Jun; 5(2):108-16. PubMed ID: 21305368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double Positivity for HPV DNA/P16
    Alsharif U; Hofmann M; Gebhard M; Tharun L; Rades D; Sieg P; Hakim SG
    Anticancer Res; 2021 Nov; 41(11):5557-5568. PubMed ID: 34732426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrin alpha 6 as a stemness driver is a novel promising target for HPV (+) head and neck squamous cell carcinoma.
    An JS; Moon JH; Kim C; No JK; Eun YG; Chang Lim Y
    Exp Cell Res; 2021 Oct; 407(2):112815. PubMed ID: 34496296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.
    Pogorzelski M; Ting S; Gauler TC; Breitenbuecher F; Vossebein I; Hoffarth S; Markowetz J; Lang S; Bergmann C; Brandau S; Jawad JA; Schmid KW; Schuler M; Kasper S
    Cell Death Dis; 2014 Feb; 5(2):e1091. PubMed ID: 24577089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern Ireland.
    Craig SG; Anderson LA; Moran M; Graham L; Currie K; Rooney K; Robinson M; Bingham V; Cuschieri KS; McQuaid S; Schache AG; Jones TM; McCance D; Salto-Tellez M; McDade SS; James JA
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):31-38. PubMed ID: 31666283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma.
    Chung CH; Zhang Q; Kong CS; Harris J; Fertig EJ; Harari PM; Wang D; Redmond KP; Shenouda G; Trotti A; Raben D; Gillison ML; Jordan RC; Le QT
    J Clin Oncol; 2014 Dec; 32(35):3930-8. PubMed ID: 25267748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-time PCR HPV genotyping in fine needle aspirations of metastatic head and neck squamous cell carcinoma: Exposing the limitations of conventional p16 immunostaining.
    El-Salem F; Mansour M; Gitman M; Miles BA; Posner MR; Bakst RL; Genden EM; Westra WH
    Oral Oncol; 2019 Mar; 90():74-79. PubMed ID: 30846180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.
    Hakima L; Adler E; Prystowsky M; Schiff B; Schlecht N; Fox A; Suhrland M; Khader SN
    Diagn Cytopathol; 2015 Sep; 43(9):683-7. PubMed ID: 25964135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients.
    Chai RC; Lim Y; Frazer IH; Wan Y; Perry C; Jones L; Lambie D; Punyadeera C
    BMC Cancer; 2016 Mar; 16():178. PubMed ID: 26940728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p16 immunohistochemistry for primary tumor detection in HPV-positive squamous cell carcinoma of unknown primary.
    Shan A; Rooper LM; Ryan JF; Eisele DW; Fakhry C
    Am J Otolaryngol; 2021; 42(5):103015. PubMed ID: 33857776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of Glial cell derived neurotrophic factor in head and neck cancer.
    Cao H; He Q; Eyben RV; Bloomstein J; Nambiar DK; Viswanathan V; Aggarwal S; Kwok S; Liang R; Koong AJ; Lewis JS; Kong C; Xiao N; Le QT
    PLoS One; 2020; 15(2):e0229311. PubMed ID: 32084217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.